← Back to search

IMMEDICA PHARMA US INC.

Chicago, IL, 60642

Prime contracting experience

1 record from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
Office of Assistant Secretary for Preparedness and Response
DEVELOPMENT OF INTRAVENOUS DRUG GANAXOLONE—$33,656,933Aug 12, 2024Sep 8, 2020 – Jul 31, 2025

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

IMMEDICA PHARMA US INC. – Chicago, IL | UEI MS6UM2NBDW91 | FedSub